Sort
21,281 grants matching “influenza”
New Vaccine Surveillance Network
$300,000John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · IP
DEVELOPING SUSTAINABLE INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO AVIAN AND
$300,000Birjees Mazher Kazi · National Institute Of Health · U51 · FY2013 · IP
Development of a novel highly effective influenza vaccine
$300,000Pamuk Bilsel · Flugen, Inc. · R41 · FY2015 · AI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$300,000Kathy L Rowlen · Indevr, Inc. · R43 · FY2013 · AI
Surrogate endpoints for correlating protective immunity in response to influenza
$300,000Gary Fujii · Molecular Express, Inc. · R43 · FY2009 · AI
Preparedness and Response to Avian and Pandemic Influenza in Rwanda
$300,000Vianney Nizeyimana · Treatment Research Aids Center (Trac) · U51 · FY2008 · IP
Development of a vaccine for prevention of Haemophilus influenzae otitis media
$300,000Stephen J. Barenkamp · Saint Louis University · R01 · FY2012 · AI
Development of Influenza Surveillance Networks Overseas
$300,000Ung Sam An · Royal Government Of Cambodia · U51 · FY2010 · CI
Development of antibody drug conjugates as pan-filo antivirals
$300,000Gai Liu · Microbiotix, Inc · R43 · FY2023 · AI
SUSTAINING INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO
$300,000Samir Refaey · Egyptian Ministry Of Health & Population · U51 · FY2013 · IP
Identification of Novel Broad Spectrum Influenza Virus Inhibitors
$300,000Arnab Basu · Microbiotix, Inc · R43 · FY2009 · AI
Therapy for drug resistant influenza strains by nucleic acid targeting of respiratory airways
$300,000Charles Houston Jones · Abcombi Biosciences, Inc. · R41 · FY2016 · AI
Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines
$300,000Paul Veness Munson · Orlance, Inc. · R43 · FY2018 · AI
Novel anti-viral agents to treat influenza
$300,000Dipanwita Basu · Alexander Biodiscoveries, Llc · R43 · FY2011 · AI
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$300,000Remigio M Olveda · Research Institute For Tropical Medicine · U50 · FY2007 · CI
Enhanced Surveillance for New Vaccine Preventable Diseases
$300,000Janet A Englund · Seattle Children'S Hospital · U01 · FY2019 · IP
Novel Protein Adjuvant for Flu Vaccines
$300,000Jiu Jiang · Dmx, Inc. · R43 · FY2011 · AI
Development of highly potent human monoclonals for RSV immunoprophylaxis
$300,000Larry Zeitlin · Mapp Biopharmaceutical, Inc. · R43 · FY2019 · AI
Ad4 vectored HIV-Env vaccines with improved immunogenicity
$300,000Marc Joseph Gurwith · Paxvax, Inc. · R43 · FY2010 · AI
Core D: Bmem Analysis Core
$300,000Masayuki Kuraoka · Boston Children'S Hospital · P01 · FY2024 · AI
Development of a Tetravalent Dengue Vaccine that Links Innate and Adaptive Immuni
$300,000Lynda G Tussey · Vaxinnate Corporation · R43 · FY2008 · AI
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$300,000Tom Kiedrzynski · Secretariat Of The Pacific Community · U50 · FY2007 · CI
AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS
$300,000Hong Qi · Qoolabs, Inc. · N43 · FY2020 · AI
Broadly protective (universal) virus-like particle (VLP) based influenza vaccine
$300,000Jose M Galarza · Technovax, Inc. · R43 · FY2013 · AI
Multiplexed vaccine titer test
$300,000David Schwartz · Solulink Biosciences · R43 · FY2010 · AI